Vaginal micronized progesterone in continuous hormone replacement therapy: A prospective randomized study;Il progesterone vaginale micronizzato nella terapia ormonale sostitutiva continua. Studio prospettico randomizzato

Minerva Ginecologica

Volumn 54, Issue 6, 2002, Pages 519-530

  Ferrero, S ^a   Gerbaldo, D ^a   Fulcheri, E ^a   Cristoforoni, P ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

Hormone replacement therapy; Menopause; Progesterone, administration and dosage

Indexed keywords

MEDROXYPROGESTERONE ACETATE; NORETHISTERONE ACETATE; PROGESTERONE;

ADULT; AGED; ARTICLE; DRUG EFFECT; ENDOMETRIUM ATROPHY; ESTROGEN THERAPY; FEMALE; HORMONAL REGULATION; HORMONAL THERAPY; HORMONE SUBSTITUTION; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MENOPAUSAL SYNDROME; MENSTRUAL CYCLE; POSTMENOPAUSE; RISK BENEFIT ANALYSIS; SUBSTITUTION THERAPY;

ADMINISTRATION, INTRAVAGINAL; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; MIDDLE AGED; PROGESTERONE; PROSPECTIVE STUDIES;

EID: 0036964338     PISSN: 00264784     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Studd JWW, Thom MH. Oestrogen and endometrial cancer. In: Studd JWW, editor. Progress in obsterics and gynaecology. Edinburgh: Churcill-Livingstone; 1981;1. p. 182-98.
2. Gambrell RD, Bagnell CA, Greenblatt RB. Role of estrogens and progesterone in the etiology and the prevention of the endometrial cancer: review. Am J Obstet Gynecol 1983;146:696-707.
3. Voigt LF, Weiss NS, Chu J, Daling JR, McKnight B, van Belle G. Progestagen supplementation of exogenous oestrogens and risk of endometrial cancer. Lancet 1991;338:274-7.
4. Lane G, Whitehead, MI, King, RJB. Effects of oestrogens and progestogens on the histology, ultrastructure, and biochemistry of the postmenopausal endometrium. Int Med 1982;2:13-8.
5. Lane G, Siddle NC, Ryder TA, Pryse-Davies J, King RJB, Whitehead MI. Dose dependent effects of oral progesterone on the oestrogenized postmenopausal endometrium. Br Med J 1983;287:1241-5.
6. Vihko R, Maentausta O. Effects of progesterone on the human endometrium. In: Genazzani AR, Petraglia F, editors. Hormones in gynecological endocrinology. Roma: Parthenon Publishing Group Ltd; 1992. p. 577-85.
7. Fahraeus L, Larsson-Cohn U, Wallentin L. L-norgestrel and progesterone have different influences on plasma lipoproteins. Eur J Clin Invest 1983;13:447-53.
8. Ottoson U, Johansson B, Von Schoultz B. Subfractions of high-density lipoprotein cholesterol during estrogen replacement therapy: a comparison between progestogen and natural progesterone. Am J Obstet Gynecol 1985;151:746-50.
9. Knopp R. Cardiovascular effects of endogenous sex hormones over a women's life. Am J Obstet Gynecol 1988;158:1630-43.
10. Lobo RA. The role of progestins in hormone replacement therapy. Am J Obstet Gynecol 1992;166: 1997-2004.
11. Glazener CMA, Bailey I, Hull MGR. Effectiveness of vaginal administration of progesterone. Br J Obstet Gynaecol 1985;92:364-8.
12. Miles RA, Paulson RJ, Lobo RA, Press MF, Dahmoush L, Sauer MV. Pharmacokinetics and endometrial tissue levels of progesterone after administration by intramuscular and vaginal routes: a comparative study. Fertil Steril 1994;62:485-90.
13. Nillius SJ, Johansson EDB. Plasma levels of progesterone after vaginal, rectal or intramuscular administration of progesterone. Am J Obstet Gynecol 1971;110: 470-7.
14. Chakmakjian ZH, Zacharian NY. Bioavailability of progesterone with modes of administration. J Reprod Med 1987;32:443-8.
15. Mason WS. The use of progesterone in the treatment of PMS. Clin Obstet Gynecol 1987;30:465-79.
16. Granberg S, Wikland M, Karlsson B, Norstrom A, Friberg LG. Endometrial thickness as measured by endovaginal ultrasound for identifying endometrial abnormalities. Am J Obstet Gynecol 1991;164:47-52.
17. Cacciatore B, Ramsay T, Lehtovirta P, Ylšstalo P. Transvaginal sonography and hysteroscopy in postmenopausal bleeding. Acta Obstet Gynecol Scand 1994;73:413-6.
18. Chambers JT, Chambers SK. Endometrial sampling: When? Where? Why? With what? Clin Obstet Gynecol 1992;35:28-39.
19. Kovacs GT, Burger HG. Endometrial sampling for women on perimenopausal hormone replacement therapy. Maturitas 1988;10:259-62.
20. Archer DF, McIntyre-Seltman K, Wilborn WW, Dowling EA, Cone F, Creasy GW et al. Endometrial morphology in asymptomatic postmenopausal women. Am J Obstet Gynecol 1991;165:317-22.
21. Hamou J. Hysteroscopy and Mycrohysteroscopy. A text and atlas. San Mateo, Ca: Appleton & Lange; 1991.
22. de Cecco L, Gerbaldo D, Fulcheri E, Ferraiolo A, Baracchini P, Bernardini L et al. Endometrial response in sequential cyclic therapy assessed with associated hysteroscopy and histology. Maturitas 1992;15:199-208.
23. Hendrickson MR, Kempson RL. Endometrial hyperplasia, metaplasia and carcinoma. In: Fox H, editor. Obstetrical and gynaecological pathology. London: Churcill-Livingstone; 1987. p. 354-5.
24. Dallenbach-Hellweg G. Iatrogenic changes of the endometrium. In: Dallenbach-Hellweg G, editor. Histopathology of the endometrium. Berlin: Springer-Verlag; 1981. p. 216-56.
25. Gambrell RD. Prevention of endometrial cancer with progestogens. Maturitas 1986;8:159-68.
26. Whitehead M, King RJB, McQueen J, Campbell S. Endometrial histology and biochemistry in climateric women during estrogen and estrogen-progestogen therapy. J R Soc Med 1979;72:322-8.
27. Whitehead MI, Townsend PT, Prise-Davies J, Ryder TA, Lane G, Siddle NC et al. Actions of progestins on the morphology and biochemistry of the endometrium of postmenopausal women receiving low dose therapy. Am J Obstet Gynecol 1982;142:791-5.
28. Whitehead MI, Hillard TC, Crook D. The role and use of progestogens. Obstet Gynecol 1990;75:(Suppl. 4): 59-75.
29. Nahoul K, Dehennin L, Scholler R. Radioimmunoassay of plasma progesterone after oral administration of micronized progesterone. J Steroid Biochem Mol Biol 1987;26:241-9.
30. Nahoul K, Dehennin L, Jondet M, Roger M. Profiles of plasma estrogens, progesterone, and their metabolites after oral or vaginal administration of estradiol or progesterone. Maturitas 1993;16:185-201.
31. Whitehead MI, Townsend PT, Gill DK, Collins WP, Campbell S. Absorption and metabolism of oral progesterone. Br Med J 1980;280:825-7.
32. Ottoson UB, Carlstrom K, Damber JE, von Schoultz B. Serum concentrations of progesterone and some of its metabolites including deoxycorticosterone after oral and parenteral administration. Br J Obstet Gynaecol 1984;91:1111-9.
33. Padwick ML, Endacott J, Matson C, Whitehead MI. Absorption and metabolism of oral progesterone when administered twice daily. Fertil Steril 1986;46: 402-7.
34. Arafat ES, Hargrove JT, Maxson WS, Desiderio DM, Wentz AC, Andersen RN. Sedative and hypnotic effects of oral administration of micronized progesterone may be mediated through its metabolites. Am J Obstet Gynecol 1988;159:1203-9.
35. Mason WS, Hargrove JT. Bioavailability of oral micronized progesterone. Fertil Steril 1985;44:622-6.
36. Fraser D, Whitehead M, Schenkel L, Pryse-Davies J. Does low-dose, transdermal, norethisterone acetate reliably cause endometrial transformation in postmenopausal oestrogen-users. Maturitas 1993;16:23-30.
37. Dennerstein L, Burrows GD, Hyman G, Sharpe K. Hormone therapy and affect. Maturitas 1979;1:247-59.
38. Sherwin BB, Gelfand MM. A prospective one-year study of oestrogen and progestin in postmenopausal women: effects on clinical symptoms and lipoprotein lipids. Obstet Gynecol 1989;73:759-66.
39. Devroey P, Palermo G, Bourgain C. Progesterone administration in patients with absent ovaries. Int J Fertil 1989;34:188-93.
40. Bulletti C, de Ziegler D, Flamigni C, Giacomucci E, Polli V, Bolelli GF et al. Targeted drug delivery in gynaecology: the first uterine pass effect. Hum Reprod 1997;12:101-6.
41. Fanchin R, de Ziegler D, Bergeron C, Righini C, Torrisi C, Frydman R. Transvaginal administration of progesterone. Obstet Gynecol 1997;90:396-401.
42. Judd HL. Transdermal estradiol. A potentially improved method of hormone replacement. J Reprod Med 1994;39:343-52.
43. Varma TR. Effect of long-term therapy with estrogen and progesterone on the endometrium of postmenopausal women. Acta Obstet Gynecol Scand 1985;64: 41-8.
44. Gelfand MM, Ferenczy A. A prospective 1-year study of estrogen and progestin in postmenopausal women: effects on endometrium. Obstet Gynecol 1989;74: 398-402.
45. Fraser D, Whitehead MI, Endacott J, Morton J, Ryder TA, Pryse-Davies J. Are fixed-dose oestrogen/progestogen combinations ideal for all HRT users? Br J Obstet Gynaecol 1989;96:776-82.
46. Gerbaldo D, Ferraiolo A, Croce S, Truini M, Capitanio GL. Endometrial morphology after 12 months of vaginal oestriol therapy in post-menopausal women. Maturitas 1991;13:269-74.
47. Hawthorn RJS, Spowart K, Walsh D, McKay Hart D. The endometrial status of women on long-term continuous combined hormone replacement therapy. Br J Obstet Gvnecol 1991;98:939-42.
48. Creasy GW, Kafrissen ME, Upmalis D. Review of the endometrial effects of estrogens and progestins. Obstet Gynecol Surv 1992;47:654-78